Company / Working Capital
MARAVAI LIFESCIENCES HOLDINGS, INC. Working Capital History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$251.3M
FY2025
5-year range
$251.3M / $737.8M
FY2021-FY2025
Trend
-32.5%
vs FY2024
Sector context
#158 of 213
Health Care
What the data says
At $251M, MARAVAI LIFESCIENCES HOLDINGS, INC.'s working capital ranks #158 of 213 in the Health Care sector. Working Capital has declined for 3 consecutive years, from $738M in FY2022 to $251M in FY2025.
Based on SEC 10-K filings.
$251M in FY2025 with a 5-year CAGR of +4.6%.
Declined from $612M to $251M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -30.2%
- 5-Year CAGR
- +4.6%
- 10-Year CAGR
- -
Sector benchmark
#158 of 213 in Health CareTop 74% of 213This company $251.3M Sector average $934.6M
▼
-73.1% below sector average
Key checks
Key Insights
- MARAVAI LIFESCIENCES HOLDINGS, INC.'s working capital has declined for 3 consecutive years.
- 5-year CAGR of +4.6%, indicating consistent growth.
- In FY2025, working capital decreased 32.5% year-over-year.
- Ranks #158 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $251.3M | -32.5% |
| FY2024 | $372.2M | -39.2% |
| FY2023 | $612.4M | -17.0% |
| FY2022 | $737.8M | +14.2% |
| FY2021 | $646.3M | +221.8% |
| FY2020 | $200.8M | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026